IMC Chicago’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-69,404
Closed -$16.2M 5850
2025
Q4
$14.4M Buy
+69,404
New +$13.7M 0.01% 1000
2025
Q3
Sell
-10,952
Closed -$1.88M 3737
2025
Q2
$1.67M Buy
+10,952
New +$1.68M ﹤0.01% 2128
2025
Q1
Sell
-35,847
Closed -$5.61M 3306
2024
Q4
$5.18M Buy
+35,847
New +$5.55M ﹤0.01% 1207
2024
Q3
Sell
-14,337
Closed -$2.28M 2911
2024
Q2
$2.1M Buy
+14,337
New +$2.13M ﹤0.01% 1519
2020
Q1
Sell
-47,733
Closed -$6.77M 870
2019
Q4
$6.96M Buy
+47,733
New +$6.47M 0.02% 288

Other funds holding JNJ

IMC Chicago's JNJ Position: Q1 2026 in Review

IMC Chicago sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 69,404 shares — an estimated $16.2M sold.

IMC Chicago first reported a position in JNJ in Q4 2019 and held it in 5 quarters. The position peaked at $14.4M in Q4 2025. 4,641 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • IMC Chicago reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • IMC Chicago sold 69,404 Johnson & Johnson shares in Q1 2026, an estimated $16.2M.
  • IMC Chicago first reported a position in Johnson & Johnson in Q4 2019 and held it in 5 quarters.
  • IMC Chicago's Johnson & Johnson position peaked at $14.4M in Q4 2025.
  • 4,641 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.